Orthofix Medical INC Form 4 insider transactions

Orthofix Medical Inc. director Alan Lee Bazaar has been granted 14,965 deferred stock units as part of his compensation.

Director Charles R. Kummeth was granted 14,965 deferred stock units by Orthofix Medical Inc. as part of an equity award.

Orthofix Medical Inc. director Jason Hannon was granted 14,965 deferred stock units as part of an equity compensation award.

Orthofix Medical Inc. director Michael Finegan acquired 20,721 deferred stock units as part of an equity compensation award.

Orthofix Medical Inc. director Vickie L. Capps was granted 14,965 deferred stock units as part of an equity compensation award.

Director John B. Henneman III was granted 14,965 deferred stock units by Orthofix Medical Inc. as part of an equity award.

Orthofix Medical Inc. director Wayne Burris was granted 14,965 deferred stock units as part of a standard equity compensation award.

Director Shweta Maniar was granted 14,965 deferred stock units by Orthofix Medical Inc. as part of an equity award.

Director Michael E. Paolucci was granted 14,965 deferred stock units by Orthofix Medical Inc. as part of an equity award.

Juniper Investment Company, a 10% owner of Orthofix Medical Inc., reported the sale of 242,000 shares of common stock.

Orthofix Medical Inc. Director John B. Henneman III purchased 5,000 shares of common stock at $12.259 per share.

Engine Capital Management, LP has disclosed a series of open-market purchases increasing its beneficial ownership in Orthofix Medical Inc.

Orthofix Medical Inc. Chief Legal Officer Jorge Andres Cedron sold 3,743 shares to satisfy tax withholding obligations.

Orthofix Medical Inc. officer Lucas Vitale sold 4,269 shares of common stock to cover tax withholding obligations related to restricted stock units.

Orthofix Medical Inc.'s CFO, Julie Andrews, sold 4,788 shares of common stock to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc. officer Lucas Vitale sold common stock to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc. President and CEO Massimo Calafiore sold 12,220 shares of common stock to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc. President, Global Limb Recon, Patrick Fisher, sold shares of common stock to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc. President of Global Operations & Quality, Aviva McPherron, sold common stock to cover tax withholding obligations related to restricted stock unit settlement.

Orthofix Medical Inc.'s President of Global Spine, Max Reinhardt, sold shares to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc.'s Chief Legal Officer, Jorge Andres Cedron, sold common stock to cover tax withholding obligations related to restricted stock unit settlements.

Orthofix Medical Inc. President & CEO Massimo Calafiore received grants of 115,119 restricted stock units and 273,279 employee stock options.

Orthofix Medical Inc. President of Global Operations & Quality, Aviva McPherron, received grants of restricted stock units and employee stock options.

Orthofix Medical Inc.'s CFO, Julie Andrews, was granted 35,495 restricted stock units and 84,261 stock options as part of a pre-planned compensation arrangement.

Orthofix Medical Inc.'s Chief Legal Officer, Jorge Andres Cedron, received a grant of 23,024 restricted stock units and 54,656 employee stock options.

Orthofix Medical Inc. officer Lucas Vitale received grants of restricted stock units and employee stock options, increasing his beneficial ownership.

Orthofix Medical Inc.'s President of Global Limb Recon, Patrick Fisher, was granted 21,105 restricted stock units and 50,101 stock options.

Engine Capital Management, a 10% owner and director, reported significant open market purchases of Orthofix Medical Inc. common stock.

Orthofix Medical Inc.'s CFO, Julie Andrews, sold 4,873 shares of common stock at $14.38 per share to cover tax withholding obligations related to restricted stock unit settlement.

Orthofix Medical Inc.'s President & CEO, Massimo Calafiore, sold shares to cover tax withholding obligations related to restricted stock units.